MICHAEL ELLIOTT: Open Payments
NPI 1306312822 · WAKE VILLAGE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 57 payments from 9 companies in 2025. Trend: 2023 $708 · 2024 $778 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 27 | $318 |
| Novo Nordisk Inc | 13 | $181 |
| PFIZER INC. | 7 | $121 |
| Novartis Pharmaceuticals Corporation | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $50 |
| Corcept Therapeutics | 1 | $35 |
| GlaxoSmithKline, LLC. | 1 | $19 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Lilly USA, LLC | 1 | $15 |
Products named: VRAYLAR, Wegovy, QULIPTA, UBRELVY, ELIQUIS, LEQVIO, NURTEC ODT, VOQUEZNA.
Industry payments across TX — which companies pay providers there.
